Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-EN Version v3-FR
Language English French
Date Updated 2023-08-31 2023-08-15
Drug Identification Number 02485613 02485613
Brand name OXERVATE OXERVATE
Common or Proper name CENEGERMIN CENEGERMIN
Company Name DOMPÉ FARMACEUTICI S.P.A. DOMPÉ FARMACEUTICI S.P.A.
Ingredients
Strength(s) 0.002% 0.002%
Dosage form(s) SOLUTION SOLUTION
Route of administration OPHTHALMIC OPHTHALMIC
Packaging size 7 X 1 ML OXERVATE MULTIDOSE GLASS VIALS 7 X 1 ML OXERVATE MULTIDOSE GLASS VIALS
ATC code S01XA S01XA
ATC description
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date 2023-08-30 2023-08-30
Actual start date
Estimated end date Unknown Unknown
Actual end date
Shortage status Actual shortage Anticipated shortage
Tier 3 Status No No
Company comments SUPPLY OF CANADIAN LABELLED OXERVATE IS BEING DEPLETED/NEAR EXPIRY AND CANNOT BE REPLENISHED DUE TO LIMITED DEMAND AND SUPPLY CHALLENGES. SUPPLY OF CANADIAN LABELLED OXERVATE IS BEING DEPLETED/NEAR EXPIRY AND CANNOT BE REPLENISHED DUE TO LIMITED DEMAND AND SUPPLY CHALLENGES.
Health Canada comments